Recently, Hanamura et al. investigated the relationship between the expression of ER, progesterone receptor (PR), and AR, along with the immunological profile in breast cancer, utilizing bioinformatics analysis and flow cytometry [13]. The gene discussed is ESR1; the disease is breast carcinoma.